[HTML][HTML] Rapid Response to Remdesivir in Hospitalised COVID-19 Patients: A Propensity Score Weighted Multicentre Cohort Study
E Leegwater, L Dol, MR Benard, EE Roelofsen… - Infectious Diseases and …, 2023 - Springer
Introduction Remdesivir is a registered treatment for hospitalised patients with COVID-19
that has moderate clinical effectiveness. Anecdotally, some patients' respiratory insufficiency …
that has moderate clinical effectiveness. Anecdotally, some patients' respiratory insufficiency …
Rapid Response to Remdesivir in Hospitalised COVID-19 Patients: A Propensity Score Weighted Multicentre Cohort Study.
E Leegwater, L Dol, MR Benard… - … Diseases & Therapy, 2023 - search.ebscohost.com
Introduction: Remdesivir is a registered treatment for hospitalised patients with COVID-19
that has moderate clinical effectiveness. Anecdotally, some patients' respiratory insufficiency …
that has moderate clinical effectiveness. Anecdotally, some patients' respiratory insufficiency …
Rapid response to remdesivir in hospitalised COVID-19 patients: a propensity score weighted multicentre cohort study.
E Leegwater, L Dol, MR Benard, EE Roelofsen… - 2023 - cabidigitallibrary.org
Introduction: Remdesivir is a registered treatment for hospitalised patients with COVID-19
that has moderate clinical effectiveness. Anecdotally, some patients' respiratory insufficiency …
that has moderate clinical effectiveness. Anecdotally, some patients' respiratory insufficiency …
[HTML][HTML] Rapid Response to Remdesivir in Hospitalised COVID-19 Patients: A Propensity Score Weighted Multicentre Cohort Study
E Leegwater, L Dol, MR Benard… - Infectious Diseases …, 2023 - ncbi.nlm.nih.gov
Methods This was a multicentre observational cohort study of hospitalised patients with
COVID-19 who required supplemental oxygen and were treated with dexamethasone …
COVID-19 who required supplemental oxygen and were treated with dexamethasone …
Rapid Response to Remdesivir in Hospitalised COVID-19 Patients: A Propensity Score Weighted Multicentre Cohort Study.
E Leegwater, L Dol, MR Benard… - Infectious Diseases …, 2023 - europepmc.org
Methods This was a multicentre observational cohort study of hospitalised patients with
COVID-19 who required supplemental oxygen and were treated with dexamethasone …
COVID-19 who required supplemental oxygen and were treated with dexamethasone …
[PDF][PDF] Rapid Response to Remdesivir in Hospitalised COVID-19 Patients: A Propensity Score Weighted Multicentre Cohort Study
E Leegwater, LDMRB Eveline, E Roelofsen… - 2023 - pure.eur.nl
Introduction: Remdesivir is a registered treatment for hospitalised patients with COVID-19
that has moderate clinical effectiveness. Anecdotally, some patients' respiratory insufficiency …
that has moderate clinical effectiveness. Anecdotally, some patients' respiratory insufficiency …
Rapid Response to Remdesivir in Hospitalised COVID-19 Patients: A Propensity Score Weighted Multicentre Cohort Study
E Leegwater, L Dol, MR Benard… - Infectious Diseases …, 2023 - search.proquest.com
Methods This was a multicentre observational cohort study of hospitalised patients with
COVID-19 who required supplemental oxygen and were treated with dexamethasone …
COVID-19 who required supplemental oxygen and were treated with dexamethasone …
Rapid response to remdesivir in hospitalised COVID-19 patients: a propensity score weighted multicentre cohort study
E Leegwater, L Dol, MR Benard… - Infectious …, 2023 - scholarlypublications …
IntroductionRemdesivir is a registered treatment for hospitalised patients with COVID-19 that
has moderate clinical effectiveness. Anecdotally, some patients' respiratory insufficiency …
has moderate clinical effectiveness. Anecdotally, some patients' respiratory insufficiency …
Rapid Response to Remdesivir in Hospitalised COVID-19 Patients: A Propensity Score Weighted Multicentre Cohort Study
E Leegwater, L Dol, MR Benard… - Infectious diseases …, 2023 - pubmed.ncbi.nlm.nih.gov
Introduction Remdesivir is a registered treatment for hospitalised patients with COVID-19
that has moderate clinical effectiveness. Anecdotally, some patients' respiratory insufficiency …
that has moderate clinical effectiveness. Anecdotally, some patients' respiratory insufficiency …
Rapid Response to Remdesivir in Hospitalised COVID-19 Patients: A Propensity Score Weighted Multicentre Cohort Study.
E Leegwater, L Dol, MR Benard… - Infectious Diseases …, 2023 - europepmc.org
Methods This was a multicentre observational cohort study of hospitalised patients with
COVID-19 who required supplemental oxygen and were treated with dexamethasone …
COVID-19 who required supplemental oxygen and were treated with dexamethasone …